Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.

Khurana S, Loving CL, Manischewitz J, King LR, Gauger PC, Henningson J, Vincent AL, Golding H.

Sci Transl Med. 2013 Aug 28;5(200):200ra114. doi: 10.1126/scitranslmed.3006366.

PMID:
23986398
[PubMed - indexed for MEDLINE]
Free Article
2.

Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.

Gauger PC, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA, Vincent AL.

Viral Immunol. 2013 Oct;26(5):314-21. doi: 10.1089/vim.2013.0018. Epub 2013 Sep 13.

PMID:
24033080
[PubMed - indexed for MEDLINE]
3.

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.

Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price DA, Wilschut J, de Haan A.

PLoS One. 2012;7(1):e30898. doi: 10.1371/journal.pone.0030898. Epub 2012 Jan 27.

PMID:
22303469
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23.

PMID:
21310191
[PubMed - indexed for MEDLINE]
5.

Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.

Hu W, Chen A, Miao Y, Xia S, Ling Z, Xu K, Wang T, Xu Y, Cui J, Wu H, Hu G, Tian L, Wang L, Shu Y, Ma X, Xu B, Zhang J, Lin X, Bian C, Sun B.

Virology. 2013 Jan 20;435(2):320-8. doi: 10.1016/j.virol.2012.09.034. Epub 2012 Oct 16.

PMID:
23084424
[PubMed - indexed for MEDLINE]
Free Article
6.

Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.

Strengell M, Ikonen N, Ziegler T, Julkunen I.

PLoS One. 2011;6(10):e25848. doi: 10.1371/journal.pone.0025848. Epub 2011 Oct 11.

PMID:
22022458
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.

Wei CJ, Yassine HM, McTamney PM, Gall JG, Whittle JR, Boyington JC, Nabel GJ.

Sci Transl Med. 2012 Aug 15;4(147):147ra114. doi: 10.1126/scitranslmed.3004273.

PMID:
22896678
[PubMed - indexed for MEDLINE]
Free Article
8.

Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection.

Gocník M, Fislová T, Mucha V, Sládková T, Russ G, Kostolansky F, Varecková E.

J Gen Virol. 2008 Apr;89(Pt 4):958-67. doi: 10.1099/vir.0.83524-0.

PMID:
18343837
[PubMed - indexed for MEDLINE]
Free Article
9.

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.

Khurana S, Wu J, Verma N, Verma S, Raghunandan R, Manischewitz J, King LR, Kpamegan E, Pincus S, Smith G, Glenn G, Golding H.

J Virol. 2011 Nov;85(21):10945-54. doi: 10.1128/JVI.05406-11. Epub 2011 Aug 24.

PMID:
21865396
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice.

Muramatsu M, Yoshida R, Miyamoto H, Tomabechi D, Kajihara M, Maruyama J, Kimura T, Manzoor R, Ito K, Takada A.

PLoS One. 2013 Aug 16;8(8):e71534. doi: 10.1371/journal.pone.0071534. eCollection 2013.

PMID:
23977065
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.

Vaccine. 2007 May 10;25(19):3871-8. Epub 2007 Feb 15.

PMID:
17337102
[PubMed - indexed for MEDLINE]
12.

Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.

Xu J, Yang D, Huang D, Xu J, Liu S, Lin H, Zhu H, Liu B, Lu C.

Arch Virol. 2013 Mar;158(3):629-37. doi: 10.1007/s00705-012-1539-9. Epub 2012 Nov 8.

PMID:
23135159
[PubMed - indexed for MEDLINE]
13.

1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans.

Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, Palese P.

J Infect Dis. 2013 Jan 1;207(1):98-105. doi: 10.1093/infdis/jis652. Epub 2012 Oct 18.

PMID:
23087428
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.

Weaver EA, Rubrum AM, Webby RJ, Barry MA.

PLoS One. 2011 Mar 28;6(3):e18314. doi: 10.1371/journal.pone.0018314.

PMID:
21464940
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.

Lee JS, Chowdhury MY, Moon HJ, Choi YK, Talactac MR, Kim JH, Park ME, Son HY, Shin KS, Kim CJ.

J Virol Methods. 2013 Dec;194(1-2):280-8. doi: 10.1016/j.jviromet.2013.08.022. Epub 2013 Sep 1.

PMID:
24004822
[PubMed - indexed for MEDLINE]
16.

A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.

Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW.

PLoS One. 2012;7(8):e42363. doi: 10.1371/journal.pone.0042363. Epub 2012 Aug 7.

PMID:
22879951
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.

Staneková Z, Király J, Stropkovská A, Mikušková T, Mucha V, Kostolanský F, Varečková E.

Acta Virol. 2011;55(1):61-7.

PMID:
21434706
[PubMed - indexed for MEDLINE]
18.

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.

Straight TM, Ottolini MG, Prince GA, Eichelberger MC.

Virol J. 2008 Mar 20;5:44. doi: 10.1186/1743-422X-5-44.

PMID:
18355405
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies.

Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR, Rao SS, Kong WP, Wang L, Nabel GJ.

Nature. 2013 Jul 4;499(7456):102-6. doi: 10.1038/nature12202. Epub 2013 May 22.

PMID:
23698367
[PubMed - indexed for MEDLINE]
20.

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, ter Meulen J, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13701-6. doi: 10.1073/pnas.1007465107. Epub 2010 Jul 6.

PMID:
20615991
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk